Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

519 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Aberrant expression of integrin and erbB subunits in breast cancer cell lines.
Shimizu H, Koyama N, Asada M, Yoshimatsu K. Shimizu H, et al. Among authors: yoshimatsu k. Int J Oncol. 2002 Nov;21(5):1073-9. Int J Oncol. 2002. PMID: 12370757
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities.
Mizui Y, Sakai T, Iwata M, Uenaka T, Okamoto K, Shimizu H, Yamori T, Yoshimatsu K, Asada M. Mizui Y, et al. Among authors: yoshimatsu k. J Antibiot (Tokyo). 2004 Mar;57(3):188-96. doi: 10.7164/antibiotics.57.188. J Antibiot (Tokyo). 2004. PMID: 15152804
An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin alpha2 on platelets as a biological marker.
Semba T, Funahashi Y, Ono N, Yamamoto Y, Sugi NH, Asada M, Yoshimatsu K, Wakabayashi T. Semba T, et al. Among authors: yoshimatsu k. Clin Cancer Res. 2004 Feb 15;10(4):1430-8. doi: 10.1158/1078-0432.ccr-0109-03. Clin Cancer Res. 2004. PMID: 14977846
A novel carbazole topoisomerase II poison, ER-37328: potent tumoricidal activity against human solid tumors in vitro and in vivo.
Nakamura K, Uenaka T, Nagasu T, Sugumi H, Yamaguchi A, Kotake Y, Okada T, Kamata J, Niijima J, Taniguchi T, Koyanagi N, Yoshino H, Kitoh K, Yoshimatsu K. Nakamura K, et al. Among authors: yoshimatsu k. Cancer Sci. 2003 Jan;94(1):119-24. doi: 10.1111/j.1349-7006.2003.tb01362.x. Cancer Sci. 2003. PMID: 12708485
Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
Shimizu H, Seiki T, Asada M, Yoshimatsu K, Koyama N. Shimizu H, et al. Among authors: yoshimatsu k. Oncogene. 2003 Feb 13;22(6):831-9. doi: 10.1038/sj.onc.1206203. Oncogene. 2003. PMID: 12584562
Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine colon 38 orthotopic transplantation model.
Nakamura K, Taniguchi T, Funahashi Y, Yoshimatsu K. Nakamura K, et al. Among authors: yoshimatsu k. Mol Cancer Ther. 2003 Jan;2(1):59-64. Mol Cancer Ther. 2003. PMID: 12533673
Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis.
Yokoi A, Kuromitsu J, Kawai T, Nagasu T, Sugi NH, Yoshimatsu K, Yoshino H, Owa T. Yokoi A, et al. Among authors: yoshimatsu k. Mol Cancer Ther. 2002 Feb;1(4):275-86. Mol Cancer Ther. 2002. PMID: 12467223
Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.
Nakamura K, Sugumi H, Yamaguchi A, Uenaka T, Kotake Y, Okada T, Kamata J, Niijima J, Nagasu T, Koyanagi N, Yoshino H, Kitoh K, Yoshimatsu K. Nakamura K, et al. Among authors: yoshimatsu k. Mol Cancer Ther. 2002 Jan;1(3):169-75. Mol Cancer Ther. 2002. PMID: 12467211
Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium.
Funahashi Y, Sugi NH, Semba T, Yamamoto Y, Hamaoka S, Tsukahara-Tamai N, Ozawa Y, Tsuruoka A, Nara K, Takahashi K, Okabe T, Kamata J, Owa T, Ueda N, Haneda T, Yonaga M, Yoshimatsu K, Wakabayashi T. Funahashi Y, et al. Among authors: yoshimatsu k. Cancer Res. 2002 Nov 1;62(21):6116-23. Cancer Res. 2002. PMID: 12414636
Array-based structure and gene expression relationship study of antitumor sulfonamides including N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide and N-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide.
Owa T, Yokoi A, Yamazaki K, Yoshimatsu K, Yamori T, Nagasu T. Owa T, et al. Among authors: yoshimatsu k. J Med Chem. 2002 Oct 24;45(22):4913-22. doi: 10.1021/jm0201060. J Med Chem. 2002. PMID: 12383017
519 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback